KALA Bio Shares Stir on Reverse Split Watch
KALA Bio shares rose 9 cents to $2.65 on light volume Wednesday, trading split-adjusted after a 1-for-50 reverse stock split aimed at regaining Nasdaq compliance. The company is shifting focus from eye drugs to developing an AI platform for life sciences, following the halt of its KPI-012 drug program.